Close

NuVasive (NUVA) Gains Japanese Approval to Resume XLIF Procedures in Q1

December 29, 2016 7:09 AM EST Send to a Friend
NuVasive, Inc. (NASDAQ: NUVA) received approval for instruments used in the eXtreme Lateral Interbody Fusion (XLIF®) procedure by the Japanese ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login